BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9088978)

  • 21. Function of Bruton's tyrosine kinase during B cell development is partially independent of its catalytic activity.
    Middendorp S; Dingjan GM; Maas A; Dahlenborg K; Hendriks RW
    J Immunol; 2003 Dec; 171(11):5988-96. PubMed ID: 14634110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of costimulatory molecules B7-1 and B7-2 in murine B cells. the CBA/N mouse reveals a role for Bruton's tyrosine kinase in CD40-mediated B7 induction.
    Goldstein MD; Debenedette MA; Hollenbaugh D; Watts TH
    Mol Immunol; 1996 Apr; 33(6):541-52. PubMed ID: 8700170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced dosage of Bruton's tyrosine kinase uncouples B cell hyperresponsiveness from autoimmunity in lyn-/- mice.
    Whyburn LR; Halcomb KE; Contreras CM; Lowell CA; Witte ON; Satterthwaite AB
    J Immunol; 2003 Aug; 171(4):1850-8. PubMed ID: 12902486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E41K mutated form of Bruton's tyrosine kinase.
    Dingjan GM; Maas A; Nawijn MC; Smit L; Voerman JS; Grosveld F; Hendriks RW
    EMBO J; 1998 Sep; 17(18):5309-20. PubMed ID: 9736610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bruton's tyrosine kinase is activated upon CD40 stimulation in human B lymphocytes.
    Brunner C; Avots A; Kreth HW; Serfling E; Schuster V
    Immunobiology; 2002 Oct; 206(4):432-40. PubMed ID: 12437073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early arrest in B cell development in transgenic mice that express the E41K Bruton's tyrosine kinase mutant under the control of the CD19 promoter region.
    Maas A; Dingjan GM; Grosveld F; Hendriks RW
    J Immunol; 1999 Jun; 162(11):6526-33. PubMed ID: 10352268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defective B cell development and function in Btk-deficient mice.
    Khan WN; Alt FW; Gerstein RM; Malynn BA; Larsson I; Rathbun G; Davidson L; Müller S; Kantor AB; Herzenberg LA
    Immunity; 1995 Sep; 3(3):283-99. PubMed ID: 7552994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Bruton's tyrosine kinase in B cells and malignancies.
    Pal Singh S; Dammeijer F; Hendriks RW
    Mol Cancer; 2018 Feb; 17(1):57. PubMed ID: 29455639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MyD88- and Bruton's tyrosine kinase-mediated signals are essential for T cell-independent pathogen-specific IgM responses.
    Alugupalli KR; Akira S; Lien E; Leong JM
    J Immunol; 2007 Mar; 178(6):3740-9. PubMed ID: 17339472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Bruton's tyrosine kinase in B cell development.
    Maas A; Hendriks RW
    Dev Immunol; 2001; 8(3-4):171-81. PubMed ID: 11785667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutting edge: lack of peripheral B cells and severe agammaglobulinemia in mice simultaneously lacking Bruton's tyrosine kinase and the B cell-specific transcriptional coactivator OBF-1.
    Schubart DB; Rolink A; Schubart K; Matthias P
    J Immunol; 2000 Jan; 164(1):18-22. PubMed ID: 10604987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes.
    Thomas JD; Sideras P; Smith CI; Vorechovský I; Chapman V; Paul WE
    Science; 1993 Jul; 261(5119):355-8. PubMed ID: 8332900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bruton's tyrosine-kinase-deficient murine B lymphocytes fail to enter S phase when stimulated with anti-immunoglobulin plus interleukin-4.
    Forssell J; Nilsson A; Sideras P
    Scand J Immunol; 1999 Feb; 49(2):155-61. PubMed ID: 10075019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mediation of transitional B cell maturation in the absence of functional Bruton's tyrosine kinase.
    Tanwar S; Dhar A; Varanasi V; Mukherjee T; Boppana R; Basak S; Bal V; George A; Rath S
    Sci Rep; 2017 Apr; 7():46029. PubMed ID: 28378771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of Bruton's tyrosine kinase in B-cell development and function in mice and man.
    Khan WN; Sideras P; Rosen FS; Alt FW
    Ann N Y Acad Sci; 1995 Sep; 764():27-38. PubMed ID: 7486535
    [No Abstract]   [Full Text] [Related]  

  • 36. Functions of Bruton's tyrosine kinase in mast and B cells.
    Kawakami Y; Kitaura J; Hata D; Yao L; Kawakami T
    J Leukoc Biol; 1999 Mar; 65(3):286-90. PubMed ID: 10080529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A sensitized genetic system for the analysis of murine B lymphocyte signal transduction pathways dependent on Bruton's tyrosine kinase.
    Satterthwaite AB; Willis F; Kanchanastit P; Fruman D; Cantley LC; Helgason CD; Humphries RK; Lowell CA; Simon M; Leitges M; Tarakhovsky A; Tedder TF; Lesche R; Wu H; Witte ON
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6687-92. PubMed ID: 10829070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Btk function in B cell development and response.
    Satterthwaite AB; Li Z; Witte ON
    Semin Immunol; 1998 Aug; 10(4):309-16. PubMed ID: 9695187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defects in early B-cell development: comparing the consequences of abnormalities in pre-BCR signaling in the human and the mouse.
    Conley ME; Rohrer J; Rapalus L; Boylin EC; Minegishi Y
    Immunol Rev; 2000 Dec; 178():75-90. PubMed ID: 11213809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice.
    Rawlings DJ; Saffran DC; Tsukada S; Largaespada DA; Grimaldi JC; Cohen L; Mohr RN; Bazan JF; Howard M; Copeland NG
    Science; 1993 Jul; 261(5119):358-61. PubMed ID: 8332901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.